Pinnacle Financial Group, Inc.’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NBIX
Pinnacle Financial Group, Inc.'s NBIX Position: Q3 2026 in Review
Pinnacle Financial Group, Inc. opened a new position in Neurocrine Biosciences (NBIX) in Q3 2026: 1,000 shares worth $142K. The stake represents 0.01% of the portfolio and ranks #566 among its holdings.
773 funds tracked by Wall St. Rank hold NBIX as of Q3 2026.
- Pinnacle Financial Group, Inc. held 1,000 shares of Neurocrine Biosciences worth $142K as of Q3 2026.
- Neurocrine Biosciences was a new Pinnacle Financial Group, Inc. position in Q3 2026.
- Neurocrine Biosciences made up 0.01% of Pinnacle Financial Group, Inc.'s portfolio in Q3 2026, its #566 holding.
- 773 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2026.
Based on Pinnacle Financial Group, Inc.'s 13F filing for Q3 2026, filed 16 Nov 2026.